OKYO Pharma OKYO
NASDAQ OKYO
$1.54 +0.04 (+2.67%)
At close: Aug 21, 2026 · 4:00 PM EDT

OKYO Pharma (OKYO) Short term Debt (2023 - 2025)

OKYO Pharma (OKYO) posted quarterly Short term Debt of $185795.0 for Q3 2025, up 10176.27% year-over-year from N/an in Q3 2024, and down 78.38% quarter-over-quarter from $859325.0 in Q1 2025.

OKYO Pharma (OKYO) Short term Debt (2023 - 2025) Analysis & Trends

OKYO Pharma (OKYO) has reported Short term Debt for 3 consecutive years, with $185795.0 the latest figure, recorded in Q3 2025.

  • In Q3 2025, Short term Debt rose 10176.27% year-over-year to $185795.0; the TTM figure through Sep 2025 stood at $185795.0 (up 10176.27% YoY), while the FY2025 annual figure was $859325.0, up 139.56% from the prior year.
  • Short term Debt fell to $185795.0 in Q3 2025 per OKYO's latest filing, from $859325.0 in the prior quarter.
  • Across five years, Short term Debt topped out at $859325.0 in Q1 2025 and bottomed at $1808.0 in Q3 2024.
  • Historically, Short term Debt has averaged $384836.6 across 3 years, with a median of $358709.0 in 2024.
  • Annual changes were most pronounced in 2024 — Short term Debt sank 99.65% — and 2025, when it soared 10176.27%.
  • OKYO Pharma's Short term Debt stood at $518546.0 in 2023, then tumbled by 99.65% to $1808.0 in 2024, then jumped by 10176.27% to $185795.0 in 2025.
  • Business Quant data shows OKYO's Short term Debt at $185795.0 in Q3 2025, $859325.0 in Q1 2025, and $1808.0 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 OKYO Pharma 1.52 Bn 1.52 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2025 185,795.00
Mar 31, 2025 859,325.00
Sep 30, 2024 1,808.00
Mar 31, 2024 358,709.00
Sep 30, 2023 518,546.00